Perfluoroalkyl substances (PFASs) are environmental pollutants with an important bioaccumulation potential. However, their metabolism and distribution in humans are not well studied. In this study, the concentrations of 21 PFASs were analyzed in 99 samples of autopsy tissues (brain, liver, lung, bone, and kidney) from subjects who had been living in Tarragona (Catalonia, Spain). The samples were analyzed by solvent extraction and online purification by turbulent flow and liquid chromatography coupled to tandem mass spectrometry. The occurrence of PFASs was confirmed in all human tissues. Although PFASs accumulation followed particular trends depending on the specific tissue, some similarities were found. In kidney and lung, perfluorobutanoic acid was the most frequent compound, and at highest concentrations (median values: 263 and 807ng/g in kidney and lung, respectively). In liver and brain, perfluorohexanoic acid showed the maximum levels (median: 68.3 and 141ng/g, respectively), while perfluorooctanoic acid was the most contributively in bone (median: 20.9ng/g). Lung tissues accumulated the highest concentration of PFASs. However, perfluorooctane sulfonic acid and perfluorooctanoic acid were more prevalent in liver and bone, respectively. To the best of our knowledge, the accumulation of different PFASs in samples of various human tissues from the same subjects is here reported for the very first time. The current results may be of high importance for the validation of physiologically based pharmacokinetic models, which are being developed for humans. However, further studies on the distribution of the same compounds in the human body are still required.

No abstract

Nanotechnology is a major innovative scientific and economic growth area. However nanomaterial residues may have a detrimental effect on human health and the environment. To date there is a lack of quantitative ecotoxicity data, and recently there has been great scientific concern about the possible adverse effects that may be associated with manufactured nanomaterials. Nanomaterials are in the 1- to 100-nm size range and can be composed of many different base materials (carbon, silicon and metals, such as gold, cadmium and selenium) and they have different shapes. Particles in the nanometer size range do occur both in nature and as a result of existing industrial processes. Nevertheless, new engineered nanomaterials and nanostructures are different because they are being fabricated from the "bottom up". Nanomaterial properties differ compared with those of the parent compounds because about 40-50% of the atoms in nanoparticles (NPs) are on the surface, resulting in greater reactivity than bulk materials. Therefore, it is expected that NPs will have different biological effects than parent compounds. In addition, release of manufactured NPs into the aquatic environment is largely an unknown. The surface properties and the very small size of NPs and nanotubes provide surfaces that may bind and transport toxic chemical pollutants, as well as possibly being toxic in their own right by generating reactive radicals. This review addresses hazards associated and ecotoxicological data on nanomaterials in the aquatic environment. Main weaknesses in ecotoxicological approaches, controversies and future needs are discussed. A brief discussion on the scarce number of analytical methods available to determinate nanomaterials in environmental samples is included.

No abstract